Recent news on Herceptin

Glaxo Plans 30 Presentations at Top Cancer Meeting  -  25 May 2007
Reuters.uk,Tykerb is currently approved for patients with advanced or metastatic HER-2 breast cancer who no longer respond to Herceptin. It is given in combination

Ventana Medical, Genentech sign pact  -  25 May 2007
Arizona Daily Star,In 1998, Herceptin was approved by the US Food and Drug Administration for use in patients who showed the overexpression of a certain cellular protein as

NICE chairman rejects "industry influence" claims  -  May 24, 2007
Pharma Times (subscription),He also robustly dismissed Labour MP Dr Howard Stoate's view that NICE's decision to recommend Roche's breast cancer treatment Herceptin (trastuzumab) was

Is Immunogen Helping to Build a 'Supercharged' Herceptin?  -  May 16, 2007
Seeking Alpha,People know Herceptin and they should; it’s Genentech’s blockbuster drug to treat breast cancer, doing over a billion in sales ($1.2 billion in 2006).

Herceptin approved in Europe for metastatic breast cancer  -  May 8, 2007
SpiritIndia,Roche announced that the European Commission has approved the use of Herceptin in combination with an aromatase inhibitor for the treatment of

Herceptin® Approved Combined With Aromatase Inhibitor For HER2 ...  -  May 5, 2007
Medical News Today (press release),Roche announced today that the European Commission has approved the use of Herceptin® (trastuzumab) in combination with an aromatase inhibitor for the

Herceptin Approved in Europe for Use in Combination with an ...  -  May 3, 2007
PharmaLive.com (press release),BASEL, Switzerland, 3 May 2007-Roche announced today that the European Commission has approved the use of Herceptin in combination with an aromatase

Herceptin approved in Europe  -  May 8, 2007
TopCancerNews.com,Herceptin, a breast cancer drug, has recently been approved in Europe, for postmenopausal patients with HER2 and hormone receptor positive metastatic

Herceptin(R) Approved in Europe for use in Combination With an ...  -  May 2, 2007
Earthtimes.orgRoche announced today that the European Commission has approved the useof Herceptin(R) (trastuzumab) in combination with an aromatase inhibitor forthe

Herceptin advocates slam Pharmac funding decision  -  May 2, 2007
New Zealand Herald,Advocates of the breast cancer drug Herceptin have responded angrily to today's decision from drug funding body Pharmac to fund nine-week courses of the

Short course best option for Herceptin  -  May 3, 2007
Scoop.co.nz,Women’s Health Action Trust welcomes the funding of the nine week course of Herceptin for women with early stage breast cancer.

Pharmac funds nine-week Herceptin course  -  May 3, 2007
New Zealand Doctor Online,Pharmac has agreed to fund a nine-week course of Herceptin, in combination with a taxane, for women with early HER-2 positive breast cancer.

Herceptin gets European OK for breast cancer  -  May 3, 2007
Scientific AmericanZURICH (Reuters) - Herceptin has been approved in Europe for the treatment of advanced breast cancer in combination with hormonal therapy, Swiss drugmaker

Herceptin gets European okay in combination with Arimidex  -  May 4, 2007
Pharma Times (subscription),Switzerland's Roche has received a new approval from European regulators for Herceptin, this time in combination with hormonal therapy for the treatment of

Roche's Herceptin gets Europe OK for breast cancer  -  May 3, 2007
ReutersVX: Quote, Profile, Research said on Thursday its Herceptin had been approved in Europe for the treatment of advanced breast cancer in combination with

Decision on Herceptin 'unintelligent and reckless'  -  May 3, 2007
Scoop.co.nz,PHARMAC's decision today to fund only 9 weeks of Herceptin from July 1 has been labeled by BCAC Chair Libby Burgess as 'unintelligent' and showing a

Researchers discovers receptor guilty for Herceptin's poor ...  -  May 2, 2007
TopCancerNews.com,Herceptin is an agent that is targeted against the HER2 receptor and helps to slow or stop the spread of cancer cells that over express this protein.

9 weeks of Herceptin ‘better than nothing  -  May 3, 2007
New Zealand Herald,Pharmac has agreed to fund a nine-week course of Herceptin combined with a taxane drug for women with early HER2-positive breast cancer.

Nod for funding of nine-week Herceptin breast cancer treatment  -  May 3, 2007
Radio New Zealand,The State drug-buying agency Pharmac has confirmed that it will fund Herceptin for treatment of early breast cancer from July.

Pharmac approves 9-wk Herceptin course  -  May 2, 2007
Stuff.co.nz,Pharmac has given the go ahead to fund a nine-week course of Herceptin in combination with a taxane drug for women with early HER2-positive breast cancer.

Neoadjuvant Taxotere®, Navelbine®, and Herceptin® Active for ...  -  May 3, 2007
Cancer Consultants (press release),To evaluate patient outcomes after neoadjuvant treatment with Taxotere, Navelbine, and Herceptin, researchers conducted a Phase II clinical trial among 31

Roche's Herceptin receives EU approval for breast cancer ...  -  May 2, 2007
Forbes,ZURICH (Thomson Financial) - Roche Holdings AG said the European Commission has approved the use of Herceptin in combination with an aromatase inhibitor for

Herceptin Decision Unethical – Peters  -  May 2, 2007
Scoop.co.nz,New Zealand First leader Winston Peters says the decision to fund a larger nine-week trial of Herceptin for women with early breast cancer is unethical and

Women to seek judicial review on Herceptin decision  -  Apr 26, 2007
New Zealand Herald,A group of eight Herceptin campaigners is filing for a judicial review of how Pharmac decided not to fund Herceptin for full-year courses for early-stage

Cancer experts bullied over Herceptin  -  May 2, 2007
Scoop.co.nz,New Zealand's cancer experts were bullied into approving Labour's nine week Herceptin programme despite preferring the proven 12-month course,

Pharmac defends decision for nine-week limit on Herceptin funding  -  May 2, 2007
TV3 News,Pharmac's defending its decision to approve funding for a nine week course of breast cancer drug Herceptin - rather than one year as sufferers wanted.

Funding For Short Herceptin Treatment  -  May 2, 2007
newswire.co.nz,State drug-buying agency Pharmac has confirmed that it will fund herceptin for treatment of early breast cancer from July. Herceptin will be funded under a

Pharmac's Herceptin decision slammed  -  May 3, 2007
TV3 News,Pharmac has the backing of a women's group in its move to fund the cancer drug Herceptin for only short 9-week courses. Adocates of the drug have reacted

Marker Associated with Response to Herceptin® in Breast Cancer  -  Apr 25, 2007
Cancer Consultants (press release),Herceptin is an agent that is targeted against the HER2 receptor and helps to slow or stop the spread of cancer cells that overexpress HER2.

Herceptin available from July 1  -  May 2, 2007
TVNZ,Pharmac and district health boards are funding nine-week courses of the drug. They say it will cost about $6 million a year and benefit around 350 women.

Herceptin approved for nine-week courses  -  May 2, 2007
Newstalk ZB,PHARMAC and district health boards are funding nine-week courses of the drug. They say it will cost about $6 million a year, benefiting around 350 women.

COMUNICADO: Se aprueba la utilización de Herceptin(R) en Europa en ...  -  May 3, 2007
Terra España,...(i) Kaufman, B. Trastuzumab plus anastrozole prolongs progression-free survival in postmenopausal women with HER2 positive, hormone-dependent metastatic

Health reporting needs the QALY treatment  -  May 21, 2007
CBC News,Oh, there's that woman with breast cancer demanding to get the drug Herceptin. It does work, but benefits cost so much that Derek Machin,

Linda Nolan: It wasn't just a case of 'the show must go on'  -  May 24, 2007
Belfast Telegraph,When the controversy was raging over the 'postcode lottery' surrounding the availability of the costly drug Herceptin, the Nolans got together and decided

Breast Cancer Breakthroughs  -  26 Apr 2007
American Enterprise Institute,Among them are taxanes, a drug called Herceptin which hones in on a specific receptor expressed by some breast cancers, and advanced hormone therapies such

Insurance offers life-saver cover  -  26 Apr 2007
This is Money,Last year, the NHS finally caved in to pressure from breast cancer sufferers to give them Herceptin in the early stages of the disease.

Marker Associated with Response to Herceptin® in Breast Cancer  -  Apr 25, 2007
Cancer Consultants (press release),Herceptin is an agent that is targeted against the HER2 receptor and helps to slow or stop the spread of cancer cells that overexpress HER2.

Skipping raises $5000-plus for women on Herceptin  -  Apr 23, 2007
Scoop.co.nz,The money will go to women with the HER2-positive form of breast cancer targeted by Herceptin, a treatment that is not funded for by government agency

National Herceptin Fundraiser April 22  -  Apr 18, 2007
Scoop.co.nz,All funds raised in each area will go towards supporting Herceptin treatment for women living in the same community. Among those ‘skipping for life’ at the

Herceptin sales boost drugmaker  -  Apr 18, 2007
BBC News,Sales of Herceptin, approved last year by US and EU authorities for treatment of early stage and advanced breast cancer, rose 36% in the three months.

Genentech Tests Stronger Herceptin Cancer Drug, May Boost Sales  -  Apr 13, 2007
BloombergThe experimental therapy increased the effectiveness of Herceptin against drug-resistant cancer cells by linking the drug with chemical toxins, according to

Patricia backs race for Cancer Research  -  Apr 23, 2007
Belfast Telegraph,Patricia McPeake who fronted the 'Herceptin Campaign' said it was vitally important to raise awareness and funds for all sorts of cancer research.

Living with cancer — and thriving  -  Apr 22, 2007
Los Angeles Daily News,Luckily for Grimes, she was a match for Herceptin. She started weekly intravenous treatment in association with another new smart drug called Avastin

With chemo over, fear and hope go hand in hand  -  Apr 23, 2007
Louisville Courier-Journal,Megan still faces nine months of a medication called Herceptin, which is not officially considered a chemo drug but is administered in the same way,

Herceptin Fundraising Campaign To Be Launched  -  Apr 11, 2007
Scoop.co.nz,Skip for Life, run by volunteers and soon to be registered as a charity, will set aside funds for women recommended by their oncologists for Herceptin,

Event to fund drug  -  Apr 22, 2007
The Press,Women unable to afford the expensive breast cancer treatment Herceptin have been given a chance through a national fund-raising event.

Herceptin plan draws 250 submissions  -  Apr 12, 2007
Radio New Zealand,A Pharmac consultation on funding a nine-week course of the breast cancer drug Herceptin ended on Thursday night with about 250 submissions received.

Developing world can expect a 'pandemic of cancer' by 2020  -  Apr 23, 2007
News-Medical.net,The cost in the UK to treat a breast cancer patient with Herceptin is around $50000; in comparison, per capita government expenditure on health in 2003,

Wurzel's Tommy supports Pink Walk  -  Apr 23, 2007
Yeovil Express,Also supporting the Pink Peacock Walk is Barbara Clark who successfully fought to have the drug Herceptin provided on the NHS.

Why my struggle to be given new cancer therapy was worth it  -  Apr 21, 2007
Belfast Telegraph,An Ulster woman told last night how a hard-fought battle to receive Herceptin saved her life - and left her feeling "just fine".

Tele calls on Assembly to scrap prescription charges for all patients  -  Apr 23, 2007
Belfast Telegraph,And Patricia McPeake, the Castledawson woman who headed up a battle for early breast cancer sufferers to be given Herceptin, also voiced support for the

Neoadjuvant Taxotere®, Navelbine® and Herceptin® Active for ...  -  Apr 4, 2007
Cancer Consultants (press release),Researchers involved in a multicenter trial have reported that a regimen of Taxotere (docetaxel), Navelbine (venorelbine) and Herceptin® produces a 39%

Research shows Herceptin helps  -  Apr 1, 2007
The Mercury (subscription),A trial including 469 women has shown that the combination of trastuzumab (Herceptin) with chemotherapy yielded a 45% overall response rate, compared to a

Asia's Cancer Rate May Pose Threat to Economic Growth (Update1)  -  Apr 22, 2007
BloombergIt costs close to $50000 in Great Britain to treat a breast cancer patient using Herceptin, which generated $3.2 billion in sales last year for Roche and

Roche, Novartis Cancer Drugs Too Expensive for Asian Countries  -  Apr 22, 2007
BloombergThese drugs offer doctors and patients alternatives to toxic chemotherapies and include Roche's Herceptin and Avastin, and Gleevec from Novartis.

Nelson women outskip main centres  -  Apr 22, 2007
The Nelson Mail,Their treatment options were limited because of a $75000 price tag attached to receiving the drug Herceptin over a 12-month period.

Hodgson doesn’t understand Herceptin stats  -  Mar 27, 2007
Scoop.co.nz,The Health Minister is continuing to show his complete lack of understanding of the benefits of Herceptin, says National’s Associate Health spokeswoman,

Herceptin Lawyers 'appalled And Perplexed' By NICE Refusal To ...  -  Mar 29, 2007
Medical News Today (press release),The law firm, Irwin Mitchell, who fought successfully for the use of the drug Herceptin for breast cancer sufferers have said that they are 'appalled and

Wellingtonians “Skipping For Lifeâ€?  -  Apr 18, 2007
Scoop.co.nz,Pharmac should abandon its proposed funding of nine-week Herceptin treatments for women with early-stage HER2-positive breast cancer, says a local academic

Cancer Time Bomb Threatening Economic Infrastructure  -  Apr 23, 2007
MedIndia,Most of the population does not have the reach to proper treatment like Herceptin and Avastin. The high cost of treatment for cancer is crippling the

Tribute for lives saved  -  Apr 19, 2007
Toronto Star,Slamon's genetic research led to the development of the anti-cancer drug Herceptin, a non-toxic, targeted drug therapy that is credited for extending and

Spreading the Word About "26.2 With Donna" at the Boston Marathon  -  Apr 21, 2007
First Coast News,A trial last year combining the drug herceptin with chemotherapy produced a 52 percent drop in the recurrence of a particularly vicious type of breast

Roche Posts Strong First Quarter Sales – Upgrade of Core Earnings ...  -  Apr 18, 2007
PharmaLive.com (press release),The expanding range of indications for our leading cancer drugs Avastin, Herceptin, Xeloda and MabThera establishes these innovative drugs as the gold

Kids Miss Out On Penicillin For Rheumatic Fever  -  Apr 22, 2007
Scoop.co.nz,It happened with Herceptin and it could have happened with bicillin. “Pharmac has said that it won’t consider funding bicillin until it has been registered.

Novel method to expand the number of immune system "natural killer ...  -  Apr 20, 2007
News-Medical.net,In subsequent experiments, they showed that the combination of NK cells and Herceptin was effective in killing HER2/neu-expressing breast cancer cells,

Health insurance a matter of life and death for businesses  -  Apr 22, 2007
Independent Community Newspaper,I'm not HER2 positive, but if I were, Southern Cross would not have paid for Herceptin, which costs up to $120000 a year. My trauma insurance would have had

New research may help identify patients most likely to benefit ...  -  Apr 20, 2007
News-Medical.net,Since these so-called "triple-negative" tumors are treatable with neither Herceptin nor antiestrogen drugs, the prognosis for patients with the tumors has

Dose of reality on drug  -  Apr 5, 2007
Philadelphia Inquirer,Herceptin made big news last week, as three major studies showed that women who used the drug early in treatment had breast-cancer recurrence rates cut in

Five awarded 'mini-Nobels'  -  Apr 18, 2007
Toronto Star,Slamon's genetic research lead to the development of the anti-cancer drug Herceptin, an amazingly non-toxic, targeted drug therapy that is credited for

Delight at cancer mum's 'miracle baby'  -  Apr 20, 2007
ic Wales,..."I have had to stop taking Herceptin, which is my back-up drug against the cancer returning and if it does come back it could lead to a more tricky

Roche First-Quarter Sales Rise 16% on Cancer Drugs (Update2)  -  Apr 17, 2007
BloombergAvastin and Herceptin, developed by the company's US partner Genentech Inc., are helping sales grow faster than at industry peers such as AstraZeneca Plc,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional